Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases)

被引:0
|
作者
Denerolle, P
Bourdoiseau, G
机构
[1] Ecole Vet Lyon, Dept Pathol & Clin Carnivores Domest, Parasitol Lab, F-69280 Marcy Etoile, France
[2] Clin Vet, Seyne Mer, France
关键词
dogs; Leishmania infantum; protozoal disease; therapy;
D O I
10.1892/0891-6640(1999)013<0413:CAAATV>2.3.CO;2
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The aim of the present study was to evaluate the long-term clinical outcome for dogs with leishmaniasis that were treated with 3 different protocols: combined treatment with antimony and allopurinol, antimony alone, or allopurinol alone. Ninety-six dogs included in this study were determined to have leishmaniasis on the basis of (1) clinical features, (2) identification of the parasite in smears of lymph node, bone marrow aspirates, or skin biopsies, and (3) specific immunofluorescent assay. Three groups of dogs were defined: 45 dogs (group 1) were treated with antimony (100 mg/kg SC q24h) given concurrently for 1 month with allopurinol (15 mg/kg PO q12h), and then allopurinol alone for 8 months at the same dosage; 40 dogs (group 2) were treated with antimony alone according to the manufacturer's instructions (200 mg/kg SC q24h at 2-day intervals for 3-6 months); and 11 dogs (group 3) were treated with allopurinol alone (15 mg/kg PO q12h for 1-20 months). Information concerning signalment, history, physical examination findings, serologic testing and number of dogs becoming seronegative, outcome for each treated dog (clinical cure versus failure), and long-term survival were recorded. The numbers of the clinical cures versus failures were significantly different among the 3 groups (chi(2) = 17.77, P < .001), between groups 1 and 2 (chi(2) = 8.02, P < .01), between groups 2 and 3 (chi(2) = 11.00, P < .01), and between groups 1 and 3 (chi(2) = 16.52, P < .001). No significant difference between groups 1 and 2 was noted in the type of failure (relapse or death), serologic test results, and number of survival years (chi(2) = 2.79. P > .05). The results of the present study indicate that antimony in combination with allopurinol produces better results than antimony alone or allopurinol alone for the treatment of the canine leishmaniasis. With combination treatment, duration of treatment with antimony is shorter and long-term administration of allopurinol is well tolerated.
引用
收藏
页码:413 / 415
页数:3
相关论文
共 50 条
  • [21] EFFICACY OF ALLOPURINOL RIBONUCLEOSIDE IN THE TREATMENT OF CUTANEOUS LEISHMANIASIS
    SAENZ, R
    PAZ, H
    MARR, JJ
    CLINICAL RESEARCH, 1986, 34 (02): : A678 - A678
  • [22] Evaluating the efficacy of allopurinol for the treatment of cutaneous leishmaniasis
    D'Oliveira, A
    Machado, PRL
    Carvalho, EM
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1997, 36 (12) : 938 - 940
  • [23] Fluconazole plus allopurinol in treatment of visceral leishmaniasis
    Torrus, D
    Boix, V
    Massa, B
    Portilla, J
    PerezMateo, M
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (05) : 1042 - 1043
  • [24] Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate
    Momeni, AZ
    Reiszadae, MR
    Aminjavaheri, M
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2002, 41 (07) : 441 - 443
  • [25] Treatment of cutaneous leishmaniasis with antimony: intramuscular versus intralesional administration
    Alkhawajah, AM
    Larbi, E
    Al-Gindan, Y
    Abahussein, A
    Jain, S
    ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1997, 91 (08): : 899 - 905
  • [26] TREATMENT OF HYPERURICEMIA WITH A COMBINATION OF ALLOPURINOL AND BENZBROMARON
    MATZKIES, F
    BERG, G
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1976, 101 (43) : 1568 - 1570
  • [27] ANTIMONY DEXTRAN COMPLEX IN TREATMENT OF LEISHMANIASIS
    SENGUPTA, P
    MUKHERJEE, AM
    CHATTERJEE, A
    JOURNAL OF THE INDIAN MEDICAL ASSOCIATION, 1961, 37 (12): : 585 - &
  • [28] Pharmacodynamic Effects and Safety of Verinurad in Combination with Allopurinol Versus Allopurinol Alone in Adults with Gout: A Phase 2a, Open-Label Study
    Fleischmann, Roy
    Winkle, Peter
    Hall, Jesse
    Yan, Xiaohong
    Miner, Jeffrey N.
    Hicks, Liz
    Valdez, Shakti
    Hernandez-Illas, Martha
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [29] Molecular Basis of Antimony Treatment in Leishmaniasis
    Baiocco, Paola
    Colotti, Gianni
    Franceschini, Stefano
    Ilari, Andrea
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (08) : 2603 - 2612
  • [30] Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol
    Momeni, AZ
    Aminjavaheri, M
    EUROPEAN JOURNAL OF DERMATOLOGY, 2003, 13 (01) : 40 - 43